• TRADE NAME: Clolar (Genzyme)
  • INDICATIONS: Acute lymphoblastic leukemia
  • CLASS: Antimetabolite
  • HALF-LIFE: 5.2 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Hepatotoxic and nephrotoxic drugs

Please login to view the rest of this drug profile.

Page last updated 04/22/2024

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric